+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Type 2 diabetes mellitus: from genes to disease



Type 2 diabetes mellitus: from genes to disease



Pharmacological Reports 57(Suppl.): 20-32



The development of type 2 diabetes (T2DM) is determined by two factors: genetics and environment. The genetic background of T2DM is undoubtedly heterogeneous. Most patients with T2DM exhibit two different defects: the impairment of insulin secretion and decreased insulin sensitivity. This means that there are at least two pathophysiological pathways and at least two groups of genes that may be involved in the pathogenesis of T2DM. As far as genetic background [corrected] of T2DM is concerned, the disease may be divided into two large groups: monogenic and polygenic forms. In this review, we present genes known to cause rare monogenic forms of diabetes with predominant insulin deficiency (MODY - maturity-onset diabetes of the young, MIDD - maternally inherited diabetes with deafness) and uncommon syndromes of severe insulin resistance. We also describe some of the main approaches used to identify genes involved in the more common forms of T2D and the reasons for the lack of spectacular success in this field. Although major genes for T2DM still await to be discovered, we have probably established a "road map" that we should follow.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 050874483

Download citation: RISBibTeXText

PMID: 16415484


Related references

Is coeliac disease more prevalent in young adults with coexisting Type 1 diabetes mellitus and autoimmune thyroid disease compared with those with Type 1 diabetes mellitus alone?. Diabetic Medicine 19(4): 334-337, 2002

Type 2 diabetes mellitus: from genes to disease. Pharmacological Reports 57(Suppl. S): 20-32, 2005

Association analysis of genes in the renin-angiotensin system with subclinical cardiovascular disease in families with Type 2 diabetes mellitus: the Diabetes Heart Study. Diabetic Medicine 23(3): 228-234, 2006

Genes and environment in the pathogenesis and prevention of type 2 diabetes mellitus FT Genetik und urnwelt in der pathogenese und privention des typ 2 diabetes mellitus. 2007

Dr beta genes in type i diabetes mellitus and graves' disease patients matched for hla dr3. Acta Endocrinologica Suppl. 114(283): 12-13, 1987

Kidney transplantation on patients having diabetes mellitus type I and diabetes mellitus type II with end-stage renal disease. Diabetologia 40(SUPPL 1): A540, 1997

Oxidative Stress Genes, Antioxidants and Coronary Artery Disease in Type 2 Diabetes Mellitus. Cardiovascular and Hematological Agents in Medicinal Chemistry 14(1): 23-38, 2017

Molecular genetics of diabetes mellitus in Chinese subjects: identification of mutations in glucokinase and hepatocyte nuclear factor-1alpha genes in patients with early-onset type 2 diabetes mellitus/MODY. Diabetic Medicine 16(11): 956-963, 1999

Contribution of HLA class II genes to end stage renal disease in Mexican patients with type 2 diabetes mellitus. Human Immunology 61(10): 1031-1038, 2000

Differential patterns of insulin secretion and sensitivity in patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease versus patients with type 2 diabetes mellitus alone. Lipids in Health and Disease 13: 7, 2014

Does exercise training impact clock genes in patients with coronary artery disease and type 2 diabetes mellitus?. European Journal of Preventive Cardiology 23(13): 1375-1382, 2017

Transient neonatal diabetes mellitus, type 4, type 1 diabetes mellitus, or MODY: which disease is it, anyway?. Journal of Pediatric Endocrinology & Metabolism 15(5): 629-636, 2002

Molecular genetics of type 2 diabetes mellitus Maturity-onset diabetes of the young as a model for identifying diabetes-susceptibility genes. Biological Chemistry Hoppe-Seyler 375(SPEC SUPPL 1): S98, 1994

Serological markers of enterocyte damage and apoptosis in patients with celiac disease, autoimmune diabetes mellitus and diabetes mellitus type 2. Physiological Research 64(4): 537-546, 2016